|
|
|
Insider
Information: |
Nanavaty Maulik |
Relationship: |
|
City: |
Natick |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
177,758 |
|
Indirect Shares
|
11,017 |
|
|
Direct
Value |
$13,395,387 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
188,775 |
|
|
Total
Value |
$13,395,387 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
0.0%
|
6.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Boston Scientific Corp |
BSX |
SVP & Pres, Neuromodul... |
2022-02-28 |
177,258 |
|
0 |
Premium* |
|
Rani Therapeutics Holdings, Inc. |
RANI |
|
2023-11-16 |
500 |
2023-11-16 |
11,017 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2021-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
6,477 |
241,636 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2016-01-01 |
4 |
D |
$18.44 |
$125,337 |
D/D |
(6,797) |
146,778 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2020-08-28 |
4 |
OE |
$17.26 |
$118,248 |
D/D |
6,851 |
266,993 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2015-02-23 |
4 |
D |
$16.31 |
$116,633 |
D/D |
(7,151) |
125,363 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2014-02-24 |
4 |
D |
$13.08 |
$93,666 |
D/D |
(7,161) |
93,582 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2020-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,950 |
263,144 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2019-02-20 |
4 |
D |
$40.11 |
$319,235 |
D/D |
(7,959) |
252,123 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2019-10-03 |
4 |
OE |
$13.08 |
$125,869 |
D/D |
9,623 |
264,817 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2019-10-03 |
4 |
AS |
$39.25 |
$377,744 |
D/D |
(9,623) |
255,194 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2019-11-04 |
4 |
AS |
$41.66 |
$400,894 |
D/D |
(9,623) |
255,194 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2019-11-04 |
4 |
OE |
$13.08 |
$125,869 |
D/D |
9,623 |
264,817 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2019-12-04 |
4 |
OE |
$13.08 |
$125,869 |
D/D |
9,623 |
264,817 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2019-12-04 |
4 |
AS |
$42.89 |
$412,712 |
D/D |
(9,623) |
255,194 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2020-01-02 |
4 |
AS |
$45.33 |
$436,214 |
D/D |
(9,623) |
260,219 |
0 |
% |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2020-01-02 |
4 |
OE |
$13.08 |
$147,239 |
D/D |
9,623 |
269,842 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2020-02-03 |
4 |
AS |
$42.17 |
$405,802 |
D/D |
(9,623) |
255,194 |
0 |
% |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2020-02-03 |
4 |
OE |
$16.31 |
$156,951 |
D/D |
9,623 |
264,817 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2020-03-02 |
4 |
OE |
$16.31 |
$156,951 |
D/D |
9,623 |
276,354 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2021-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,791 |
238,784 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2018-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,005 |
218,238 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2019-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,750 |
244,101 |
0 |
- |
|
RANI |
Rani Therapeutics Holding... |
Director |
|
2022-02-03 |
4 |
A |
$0.00 |
$0 |
I/I |
11,017 |
11,017 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2016-02-22 |
4 |
D |
$17.26 |
$219,426 |
D/D |
(12,713) |
167,893 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2017-02-28 |
4 |
D |
$24.55 |
$315,026 |
D/D |
(12,832) |
207,091 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
|
2020-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
13,440 |
268,634 |
0 |
- |
|
176 Records found
|
|
Page 6 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|